Pharmacy benefit managers, or PBMs, negotiate drug prices for insurers — and sometimes own the pharmacy they're negotiating ...

Some of the largest US health-care companies own pharmacy benefit management units that negotiate drug prices for employers and other customers. If enacted, the policy would compel CVS Health Corp., ...

Tesla stock hits a record high, Exxon Mobil outlines extensive investments over next 6 years, and more news to start your day ...

And now Walgreens is reportedly looking to escape the public market. Walgreens and private equity firm Sycamore Partners are ...

Red Stone Equity Partners closed Fund 113 at $263.2 million, marking its largest LIHTC equity investment vehicle to date.

A third of U.S. pharmacies have closed since 2010. Among them, both independent and chain pharmacies struggling to make money in the industry.

The fallout from the fatal shooting of United Healthcare CEO Brain Thompson has led to a tumble in stock values for major insurance companies.

The bill, sponsored by U.S. Senators Elizabeth Warren, a Democrat, and Josh Hawley, a Republican, will force companies owning health insurers or pharmacy benefit managers to divest their businesses ...

Today, the stock moved below the $52.50 level, posting its lowest close since 2020. With a bearish trend in CVS’ 50- and ...

Pharmacy-benefit managers (PBMs) have been scrutinized for their role in drug distribution for years. Now a bipartisan group of lawmakers is threatening to break up the companies behind these ...

The PBM Act would make companies like CVS and UnitedHealth that own health insurers or PBMs sell pharmacy assets. It would help independent pharmacies, but may not help patients, according to one ...

CVS could wind up as the only pharmacy stock in the U.S. if Walgreens goes private. But the drugstore chain, worth about $65 ...